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Abstract
The 'omics' era and its concomitant technological advances have brought great insight into genetics. One of the
most promising fields within human genetics is the prediction of physical traits from analysis of genetic material.
Besides the predictive potential of DNA, the traceability of pathogenic agents in the human body through molecular
analysis is also a field to be further exploited. In this review, we aim to discuss specific aspects of phenotypic
prediction by analysing DNA, with special emphasis on normal variation, and the application of a technology known
as ‘Forensic DNA Phenotyping’ (FDP). We also suggest the term ‘Phenotype Informative Markers’ (PIMs) to
designate any molecular markers responsible for normal or pathological human phenotypic variation. In addition, we
raise some recommendations related to forensic genetics, the molecular diagnosis of human diseases, and the
traceability of pathogens in the human body, giving special emphasis to the need for validation of these tests with
strict protocols. Some relevant concerns about privacy, ethics, and legality of such predictions have also been
discussed. Finally, we look at perspectives on the use of epigenetic tools, and quote some examples of what has
been done in this specific field.
Keywords: Legal concerns on prediction; Phenotype informative
markers; Forensic DNA phenotyping; Molecular diagnosis; Pathogen
traceability
Introduction
Since the discovery of the DNA double helix [1], the development of
innovative sequencing technologies [2-4] and different modalities of
the PCR technique [5], among others, have led to substantial
improvements in the available information detailing molecular
markers for normal human phenotypic constitution/variation, as well
as several specific markers that indicate predisposition to certain
diseases. These advances have fuelled important areas of research such
as forensic genetics and preventive medicine. The number of
publications since 1953 (year that the DNA double helix was described
by Watson and Crick [1]) containing the key-words "prediction" or
"molecular diagnosis" is illustrated in Figure 1. The progressive
increase in the research around these concepts clearly indicates the
importance and growing interest in genetic variation as a tool to
predict both normal and pathological phenotypes. It also denotes the
important challenges and difficulties that any established and powerful
prediction technique has to face.
Given the increasing importance of predictive methods for several
areas of human genetics and anthropology, the purpose of this paper is
to review the current cutting edge technologies. We do not intend to
do a systematic compilation of all the possible phenotypic information
to be predicted by DNA analysis, but rather we wish to give a broad
perspective on these areas, as well as some of the most relevant studies
on normal and pathological human phenotypes that can be derived
from the analysis of DNA. This information is useful mainly for
Forensic DNA Phenotyping [6] and molecular diagnosis of human
diseases. Hereafter, we will use the term “Phenotype Informative
Markers” (PIMs) to refer to genetic or molecular markers of the
human genome related with normal or pathological traits.
Understanding the genotype-phenotype relationship
When studying the genotype-phenotype relationship, we must
consider a wide view of the biological system being studied including
the (usually) unknown particularities of the genetic-phenotypic points
of view. To do so, a mandatory first step is detailed characterisation of
the phenotype, including proper delimitation of the observable
phenotypic states. This kind of approach has to be extensive, covering
as many as possible phenotypes in order to uncover possible
pleiotropic effects, and intensively, featuring each phenotype with the
maximum amount of detail, as suggested by Houle et al. [7]. Some
genotype-phenotype pathways are relatively easy to observe (for
instance, characteristics considered to be monogenic), however the
vast majority of human physical characteristics (normal or
pathological) need a more comprehensive and detailed approach to be
properly established. For practical purposes, continuous traits are
usually categorized as discrete entities. However, it is important to note
that many qualitative classifications used in the scientific literature are
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just simplifications of continuous, multivariate traits, a phenomenon
that has fuelled an intense debate in the field of systematic [8].
Figure 1: Timeline (Number of publications × Year) of terms “Prediction” and “Molecular diagnosis” used in scientific literature from 1953 to
2015.
All human phenotypes are determined by the interaction of genes
with environmental and developmental factors, each having an
influence to a variable degree. We can extend this classic definition [9]
for both polygenic and multifactorial phenotypes, as well as for
monogenic phenotypes. There is a small percentage of so-called
monogenic traits that do not directly correspond to the “rules” as
predicted by the genotype and/or characteristics that have certain
“amplitude” of influence in the expression of phenotypes (incomplete
penetrance, variable expressivity, etc.).
In polygenic and multifactorial traits, it is plausible to think that
different genetic combinations can lead to the same phenotypic result.
Notably, some of these genetic combinations are easier to detect than
others are, in a given sample. Thus, a main goal in prediction studies of
physical features from DNA is to find the specific PIM profile (that is, a
specific combination of genotypes in different loci associated with the
phenotype) related to a specific phenotype with the highest probability.
In this way, we can predict phenotypes as having a more frequent
genetic profile, that is, one could describe PIM profiles that are found
almost exclusively in specific phenotypes (Figure 2), which is, per se, a
major breakthrough in human genetics. Nevertheless, we are still far
from even knowing a tenth of the gene-gene, gene-RNA, gene-protein
connections, and epistatic interactions that occur in our genome. In
this context, any minimal amount of useful information to predict a
given phenotype is important.
As an example, we define phenotype in the qualitative spectrum as
having a hypothetical Gaussian distribution in the population. Each
color in the column in this graphic represents the probability in
predicting the respective phenotypes. For example, more red color in a
column means that the specific PIM profile has greater probability of
predicting dark brown/black eyes, and so on.
In this picture, blue represents the probability of blue/grey eyes,
green represents the probability of green eyes, orange represents the
probability of honey/light-brown eyes, and as mentioned, red
represents the probability of dark brown/black eyes. The aim of studies
regarding prediction of physical features through DNA is to find the
specific PIM profile related with a specific phenotype with highest
probability.
Notably, the definition of phenotype initially coined by Johannsen
[10] "The phenotype of an individual is the sum total of all his
expressed characters does not stop at skin surface" [11], which may
even include some human feeding behaviours, for example. A relevant
example is the tolerance for certain foods: some people like shrimps,
but cannot eat them because they have a severe allergy [12,13] or
people who may like milk or derivatives who exhibit a strong reaction
to lactose [14,15] or even people who simply "dislike" certain foods due
to greater sensitivity to bitter taste [16,17].
These are, perhaps, the more obvious examples of genetic influence
underlying certain feeding behaviors. A deep understanding of the
genotype-phenotype relationship is essential to discover the highest
genome modulation of such complex characteristics, such as responses
to foods, liquids, or drugs.
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Figure 2: Example of how the effects of genetic markers of a
polygenic trait might occur (e.g. eye color).
Despite the complexities in the genotype-phenotype map, it is now
possible to predict a handful of traits with a reasonable degree of
probability. In the following sections, we present some examples of
normal and pathological human phenotypes that are being
investigated, which are likely to be predicted in the near future with
some accuracy through DNA analysis.
PIMs for prediction of normal human traits
As pointed out by Cho and Sankar [18] and Kayser [19],
considerably less attention is given to research on genetic variants for
non-medical purposes. However, FDP technology, as well as the
characterisation of PIMs, is only possible thanks to the effort and
intensification of investments by funding agencies in these types of
research. Initiatives such as CANDELA (Consortium for the Analysis
of the Diversity and Evolution in Latin America) [20,21] and GIANT
(Genetic Investigation of ANthropocentric Traits) [22,23] are examples
of basic and applied research in these areas.
Although FDP is still under development and discussion in the legal
and administrative scope of most countries, specialists in the UK and
Netherlands have already tried to incorporate some of these
predictions into forensic routine [6,19,24], as an additional tool of
police intelligence in the pursuit of criminal suspects. The main
purpose of this tool is to reduce the number of potential suspects
through the prediction of physical features from donors of biological
samples left at the crime scene. Once the number of suspects are
reduced, a smaller ‘DNA dragnet’ (collection of DNA samples from
hundreds or even thousands of ‘volunteers’ for comparison with a
genetic profile found at a crime scene) is performed [18], and a
conventional STR (Short Tandem Repeat) profile can be generated to
help in solving the crime.
The prediction of physical traits useful for FDP consists mainly of
‘phenotype informative SNPs’ typing [25]. It is worthy to say that with
conventional STR typing it is possible to determine a unique
phenotype: the sex of the investigated sample through the amelogenin
locus. The X chromosome copy has a deletion of 6 bp in relation to the
copy of the Y chromosome, which makes it possible to differentiate
between a man (XY) and a woman (XX) [26,27]. This is done largely in
forensic practices around the world, although it was known for a long
time that this prediction test was not error-free [28] and more reliable
forensic kits have therefore been developed in more recent years
[29,30] to better confirm the gender of the biological sample.
The most promising phenotypes for FDP, in addition to sex, are
traits related to pigmentation [31,32]. There are at least ten published
studies presenting methods to explore the predictive values of
combinations of SNP alleles of pigmentation phenotypes (skin, eye and
hair colour) and presence/absence of freckles [33-42], two of which
[34,40] have already been validated [43-45]. Additional research is
under development regarding these and other phenotypes, such as
estimation of age [46-49], height [50,51], hair shape [52-54], facial
features [55,56], baldness [54,57,58], and adult stuttering [59,60].
Besides physical phenotypes, additional information of individuals can
be obtained with some reliability by analysing DNA, such as
biogeographical ancestry [61,62] and surname of the sample
[6,19,63-67].
In the context of normal phenotypes, Koops and Schellekens [6]
earlier suggested some recommendations aimed to enhance the
implementation of FDP technologies in forensic cases. Here, we
comment some of these recommendations.
1) Many of the characteristics that can be predicted by DNA are
multifactorial, resulting from the interaction of genes with specific
environmental factors. Thus, police intelligence professionals should be
aware that no method of prediction is deterministic, but probabilistic.
In other words, to say that the subject has a genetic profile for a certain
trait is not the same as to say that the individual will have a specific
phenotype determined with complete certainty; in which case, it is
important to note how much of the individual variation may be
determined by the specific genotype, taking into account
environmental features [68].
2) FDP is actually useful for excluding people from suspicion, thus
avoiding the conduction of extensive DNA dragnets (as mentioned
earlier); in fact, perhaps this is the most important aim of FDP
technology.
3) FDP only considers traces with ‘a relatively high likelihood of
manifestation, such as 75% or more (i.e. 75% or more of people with
this genotype(s) actually develop the phenotype).
4) Despite that, FDP is particularly useful when several features are
combined, and the use of a maximum of three or four independent
phenotypes is recommended for a more conservative approach. More
than that could cause the overall cumulative probability to rarely
exceed 50%, which is very low (for instance, using a threshold of 75%
in the prediction of two independent phenotypes would give a 56%
probability, which is uninformative).
5) Finally, since FDP is an emerging technology applicable in the
near future, it is essential to discuss this technology in the context of
civil society in order to standardise techniques that can be used in
forensic routines, especially with respect to the interpretation of the
generated data. More importantly, the development of a legislative
policy in each country to regulate and authorize explicitly (or not) the
fulfilment of these procedures in criminal justice is of crucial
importance.
The practical application of FDP technology requires robust
validation protocols, but it is also necessary to account for population
differences regarding the association of genetic markers used, as
suggested by Cerqueira et al. [69]. For example, although there are
highly significant polymorphisms associated with a particular
phenotype in some populations, these same PIMs have effects that are
apparently too small or null in others, suggesting that they can only be
used as markers in the context of specific populations. Furthermore,
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analysis with too few markers may not ever be sufficient for the
prediction of the various existing complex physical characteristics.
Therefore, regarding some phenotypes, we agree with Kayser and
Knijff [67] in the sense that it is ‘unlikely that FDP technology to be
achievable with small sets of genetic markers’. Technological
advancement has allowed large scale DNA sequencing and genotyping
technologies to be increasingly cheaper and faster [3,4], enabling
massive analyses of polymorphisms; therefore, the predictive power of
phenotypes is expected to be increasingly reliable. The problem with
using large sets of markers is the low quantity and quality of the
biological samples recovered in the forensic material.
In Table 1, we point out some of the more frequently studied
phenotypes in FDP technology (“Green list of FDP technology”),
which are broadly named as externally visible characteristics-EVCs
[28]. There is a good amount of information generated on these
phenotypes and some of these can be predicted with a reasonable
degree of reliability. Most of the phenotypes described in the Green list
(Table 1) still need validation for ensuring greater reliability in
prediction. Despite that FDP technology is discussed mainly in
relation to normal human characteristics, we also present a “Red list of
FDP technology”, which includes some phenotypes that still need
extensive regulation regarding ethical issues in case of to be potentially
implemented in the future. Such traits are useful nowadays only for
clinical practice (molecular diagnosis and genetic counseling) or are
even non-pathological phenotypes (e.g. personality features) that
deserve extreme caution due to ethical issues on privacy of phenotypic
data of the investigated subjects and the intrinsic difficulty of
measuring such phenotypes. Additionally, if eventually these kinds of
phenotypic characteristics are included in forensic practice,
corresponding protocols should be extensively regulated by the law to
ensure the proper access of this information by the general public and
police staff.
One of the further advantages of performing FDP is to increase the
statistical confidence in further analyses performed with conventional
STR profiles [18]. The conclusion about genetic identity or non-
identity between two samples is probabilistic. If we have predicted
phenotypic information on a suspect prior to making the STR profile,
the information gathered with the FDP technology will be useful for
increasing the reliability of the claim that a particular person actually
left his sample at the crime scene. This increase in reliability of the STR
profile has been recommended by the NRC [70] (National Research
Council, USA) when conducting tests to characterise the
biogeographic group belonging to an unknown sample.
Another FDP potentiality also includes assistance in finding missing
persons through phenotypic reconstruction from DNA extracted from
bones (for example, in forensic anthropology, the traditional method is
the analysis of the femoral size, skull and other bones to estimate
height and age) as well as to assist in phenotypic reconstruction of
missing children to check how they would look to be in adulthood
from DNA analysis, which would assist the method already used in
computer forensics through photo analysis.
Green list of FDP technology
Adult stuttering Facial features Handedness
Age Freckles Height
Ancestry Gender Skin colour
Baldness Hair colour Sample’s surname
Eye colour Hair shape EVCs in general
Red list of FDP technology
Achondroplasia Cancers Obesity
ADHD Diabetes mellitus type I or II Personality traits
Alcoholism Familial hypercholesterolemia Phenylketonuria
Alzheimer’s Disease G6PD deficiency Schizophrenia
Autism Haemophilia Sickle cell disease
Bipolar disorder Huntington’s Disease Tay-Sachs disease
Cystic fibrosis Marfan syndrome Others diseases or not-EVCs
Table 1: List of traits predicted (currently or in near future) from DNA analyses.
PIMs for molecular diagnosis
In the following two sections, we discuss the opportunities
regarding the use of DNA analysis within the medical field (molecular
diagnosis), and tracking pathogens in the human body. Furthermore,
we explain how it connects with FDP, and how the forensic field can
benefit from the practice and research avenues already experienced by
medical genetics. In the other words, we try to discuss which analysis
can be performed through DNA analysis on both forensic and medical
points of view, without attempting to exhaust such a vast theme. It is
important to clarify the different goals between the technology of FDP
and the technology of prediction of human diseases or pathogens
traceability.
A large amount of data is available on molecular methods for the
diagnosis of a handful of diseases. For example, the GeneTests website
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has information about these tests, as well as a list of laboratories
worldwide that perform them. There are over 3,000 monogenic
diseases that are possible to be diagnosed by molecular methods
(OMIM). It is important to note here that these diagnostic methods are
extremely useful to detect some diseases in pre- and postnatal testing
in order to outline preventive medicine and to avoid or mitigate future
damage to the newborn or prepare the family for such a child with an
incurable genetic disease [71]. In addition to cytogenetic prenatal tests
performed to detect structural or numerical chromosomal changes,
which cause certain syndromes (for example: Down’s – Trisomy 21;
Turner – Monosomy X without another sex chromosome; Klinefelter –
Disomy X with the presence of Y; Patau – Trisomy 13; Edwards –
Trisomy 18), there are other tests that can be done for detecting
smaller genetic mutations (e.g. SNPs) or abnormal gene products,
which are also directly associated with various diseases. The March of
Dimes global report [71] suggests conducting preventive tests for 29
conditions in the United States, including cystic fibrosis, citrullinemia,
sickle cell disease, phenylketonuria, galactosaemia.
Besides enzymatic assay or the analysis of a particular gene product
routinely performed for diagnosis of many genetic diseases, tests based
on direct analysis of DNA are performed throughout the world for
diagnosing these disorders, albeit less frequently. As outlined by
Nussbaum et al. [72], this is due to the fact that when a genetic
disorder that appears to be a single entity is studied in more detail, it
often turns out that it is genetically heterogeneous, making it difficult
to perform and interpret these tests. Therefore, it is noteworthy that
the resultant phenotype of many monogenic disorders is not caused by
just a single mutation. In contrast, there are many cases described in
the scientific reports of individuals with the same disease, who do not
have the same genetic mutation. Furthermore, there are cases reported
where the individual does not manifest the disease but has the
mutation (incomplete penetrance), which has caused for revision of
the genetic etiology of some disorders in the scientific community [72].
Thus, for many diseases, the dosage of the corresponding gene product
is determined instead of analyzing the DNA itself. Therefore,
healthcare professionals should be aware of the genetic heterogeneity
(allelic or locus) underlying the disorder being diagnosed or managed
clinically and if possible, they should do a thorough analysis of all
gene(s) (e.g. using sequencing technologies), when appropriate, to
check for possible mutations that may be responsible for the disorder
in question.
Some examples of human genetic diseases that can be diagnosed
early by direct DNA analysis include achondroplasia (Gly380Arg
detection of mutation in the receptor 3 of fibroblast growth factor
coded by FGFR3 gene, which is present in virtually all cases [73]; cystic
fibrosis (the most common mutation detected is phenylalanine amino
acid deletion at position 508 in the CFTR gene product), reviewed in
Zielenski [74]; Sickle cell anaemia (one form present a substitution of
the sixth amino acid of the beta-globin chain – Glu6Val), described in
Linus Pauling et al. [75] and reviewed by Bender and Hobbs [76];
Huntington's disease (detection of >35 copies of the trinucleotide CAG
sequence in exon 1 of the HTT gene, which encodes a polyglutamine
chain in the protein huntingtin), which can also be diagnosed in
patients and carriers by analysing a set of 22 non-redundant tagging
SNPs, described by Warby et al. [77]; Tay-Sachs disease (one way of
detecting is the insertion of four bases – TATC – in the coding
sequence of the HEXA/hexosaminidase A gene [78]; among other
diseases. More details can be found in Gene Reviews, Online
Mendelian Inheritance in Man (OMIM), Human gene mutation
database or in other sites and references previously suggested in this
section.
Beyond monogenic diseases with complete or incomplete
penetrance, some commercial tests are now available to diagnose some
multifactorial diseases (cancers, obesity, hypertriglyceridemia,
schizophrenia, autism, ADHD, Alzheimer's disease). For some of these
disorders, it is important to mention that there are some isolated
mutations already described in less common cases that have great
effects on the phenotype, therefore triggering an associated pathology,
although the predominant framework is the interaction of multiple
genetic and environmental factors in the aetiology of the disorder [68].
Some practical considerations are very relevant to this topic. As it
happens with any complex genetic trait, multifactorial diseases are
caused by interaction between genes and environment. It is important
to raise awareness that in general, just being a carrier of a particular
mutation does not mean that the subject will necessarily develop the
disease. Detailed analysis of each case and the associated family history
will be the most appropriate procedure. In such cases, genetic
counselling with a multidisciplinary approach is thus mandatory.
Interesting recommendations for personalized medicine and the use of
genetic information can be found in Burke and Psaty [79], and Chen
and Snyder [80].
In general, characterization of the genetic profile of various
mutations that affect a multifactorial trait can be useful for the affected
individual to learn to preventatively deal with their possible future
condition (e.g. through changes in lifestyle habits, among other
factors). However, proper monitoring by multidisciplinary
professionals is necessary, and genetic-medical counselling remains
extremely useful to interpret data from families affected by these
conditions, as done in prenatal diagnoses and tests for monogenic
diseases. Thus, patients need to be properly informed that even when
they carry a mutation associated with complex diseases, it is also true
that there are many mechanisms involved in the development of the
disease. This can help to prevent/stimulate the exposure to particular
crucial environmental factors and to explain that the patient’s health
and the genotype-phenotype relationship are not so direct, in most
cases [7,68]. With respect to EVCs studied in the forensic field, it is
important to mention that such traits are also complex, and are mostly
conditional on the genetic background and environmental
interference. However, there are both normal and pathological
phenotypes that can possibly be detected by PIMs, therefore, the
likelihood of developing the trait or phenotype is quite high, often
exceeding 90% probability.
Nevertheless, for many multifactorial conditions, knowledge on the
underlying phenotypic components of a macro disorder is essential in
understanding the genetic basis of a given condition. For example,
studies of predictability of human psychiatric diseases through DNA
can be benefited from studies like Cerqueira et al. [81], who associated
markers in ADRA2A with ADHD endophenotypes.
Minimising the phenotypic spectrum of a macro-disease is an
alternative to estimating traces of the disease. We emphasize here that
careful evaluation and validation should be performed before practical
application of such molecular diagnostic methods.
According to Wienroth et al. [82], the genetic advance, reflected
both in the possibility of using innovative technologies for phenotype
prediction as well as in next generation sequencing technologies,
among others, has led to the diffusion of a boundary between medical
and forensic genetics. The use of modern techniques in the forensic
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field could be guided by a rationale that the "proportionality" (serious
crimes) imposes the alternative uses of innovations in DNA profiling.
The possibility to use such modern methods of analysis in forensics,
depending on the case investigated, has also triggered ethical, social,
and legal aspects of the debates, which have been discussed later in this
review.
Pathogen traceability in the human body using
molecular markers
Existing infectious agents (bacteria, protozoa, viruses, fungi, or
worms) in the human body can be detected in various tissues or
biological fluids (blood, skin, saliva, etc.) with currently available
molecular biology techniques [5]. Traditionally, pathogens in the
human body are tracked by using immunological methods,
microscopy, or direct detection by isolation of the causative organism.
Many molecular detection techniques are still in the validation
phase and not yet widely used in laboratories, however, a few are now
available and in the process of being established in several laboratories
worldwide. Here, we mention some of these techniques to trace
pathogens responsible for some well-known diseases and indicate
references that can serve as an initial point of reading on this issue. The
list of pathogens that can be detected by DNA/RNA-based technology
is large, which includes: analysis for the detection of tuberculosis (e.g.
Mycobacterium tuberculosis [83]), human papillomavirus (HPV),
Chlamydia trachomatis and Neisseria gonorrhoeae [84-87], avian
influenza virus and influenza A (H1N1) virus [88-89], human
immunodeficiency virus (HIV) [90,91], measles [92,93], hepatitis A, B,
and C [94-97], among other pathogenic agents.
In the forensic field, this technology could be useful to analyse
infected materials (e.g., biological weapons), or in the context of
human identification, by linking biological materials found in the
crime scene to specific suspects exhibiting a specific profile of
infectious disease (e.g., linking sample donors with criminal acts) [67].
In the molecular diagnosis of pathogens and several other
molecular techniques, it is necessary to follow strict protocols for
analysis and carefully validate in-house methods aimed at avoiding
false-negative/positive results, cross-contamination, as well as
inhibitory substances in the reaction chosen for analysis, among other
factors. Notably, the choice of biological material used in the analysis
also has fundamental importance, taking into account the tissue in
which the pathogenic agents have higher affinity, and the clinical
characteristics present in the patient.
Ethical and legal perspectives
The technology of predicting phenotypes with DNA analysis is not
new, since it has already been used in the medical field for some years
and for a multitude of diseases, as seen earlier and as described in the
cited references. Medical genetic experience can teach many things to
the forensic area, and knowledge and perspectives on disease diagnosis
and ways to trace pathogens in biological material may be useful at
some point to such areas. The aspect that is new in this technology is
the discussion about the prediction of human phenotypes in the police
context, and as the technology of FDP is still recent, we have spoken
only in predicting externally visible phenotypes within criminal
prosecution, i.e. predicting information that one can visually see in the
suspect. We emphasise that this information is not confidential and is
present in civil identification documents such as driving licenses and
professional cards. Thus, the general argument is that the prediction of
these EVCs should not violate any aspect of the suspect's privacy.
The issue of privacy and the right of not knowing has been very well
discussed by Koops and Schellekens [6] and the origin of the
controversy around this topic may have been with the predictor
polymorphisms of disease or stigmatizing characteristics (genetic
predisposition to homosexuality, violence, etc.), which could
psychologically affect not only the investigation, but also third parties
not affiliated with the crime. Additionally, to find mutations in DNA
that are predictive of disease and other features indicate possible
predisposition of direct relatives not involved in the crime. However,
the aforementioned study discusses and questions whether the right of
not knowing should be respected in all cases, or if public interest in the
criminal investigation should have more value in some cases. One
solution to this issue would be to regulate the inclusion of diseases
within the scope of FDP technology that have an available cure or
diseases with relatively low impact, particularly as a last resource to
search suspects in cases of violent crimes, such as murder or rape. In
these cases, the public interest in the criminal investigation would have
greater value than the right to not disclose a genetic condition.
Alternatively, the predicted information in the course of the
investigation through DNA analysis could take place in complete
secrecy, and would be compatible with the right of not knowing if the
information from the DNA is available only at request of a suspect (or
defender). In this case, the only information that could be disclosed
would be EVCs (or neutral traits like manual dexterity), such as a
composite sketch of the suspect.
Although the first article on FDP was published in 2008 [6], very
few studies have been published in the developing countries that
discuss the legal and ethical perspectives on forensic DNA
phenotyping and/or the potential use of information in the molecular
diagnosis of diseases in the forensic field. Despite the scarce
bibliography and discussion on this issue in some nations, guiding
aspects on FDP have been very well established in Europe and United
States, such as Koops and Schellekens [6], Kayser [19], MacLean and
Lamparello [24], and Wienroth et al. [82], or the documents on
forensic genetics in the Euroforgen website.
For example, Wienroth et al. [82] raised some issues about
anticipatory governance in relation to the necessity to observe the
public/user perspectives, propose legislative changes, validate
processes for new technologies, and ensure potential safety
mechanisms, emphasizing the emerging need for a wide debate on
these aspects, in both, the forensic and the medical field with
prediction of phenotypes. Maclean and Lamparello [24] discussed
some promises and dilemmas of FDP technology (e.g. DNA
phenotypic descriptions versus eyewitness descriptions; externally
visible characteristics versus unseen characteristics; phenotyping of
stored samples versus crime scene samples; physical characteristics
versus behavioural characteristics; among others), which are very
relevant to the legal treatment of the topic, as well as to raise awareness
by technological operators.
As pointed out by Maclean and Lamparello [24], the concerns that
have been raised against the development and implementation of FDP
do not justify the elimination or prohibition of this technology. It is
also important to note that the discussion of many topics in the
medical field can either fuel or help resolve similar concerns in forensic
regulations. It is also worth mentioning that FDP should be used only
in the investigative procedure and thus would not be used in court. The
court is involved only with conventional DNA profiling (i.e. analysis of
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STRs), which has more probative value. We also mention that FDP is
useful only for tactical purposes intrinsic to police investigation, and
should only be used as evidence, since this technology does not have
incriminating or absolute power, such as that contained in an STR
profile.
There is broad consensus about a lack of regulations against
inappropriate use and legislation aimed to limit the phenotypes that
might be explored using this technology. Moreover, legislation is
needed to allow the use of FDP for “cold” cases or cases that have no
progress in the investigation, or lacking eyewitness, for example.
Another serious concern is that many countries pose silent legislation,
thus opening up the possibility of improper and inadvertent use of the
technology.
Regarding the confidentiality of genetic information investigated
within both, a medical scientific research and a forensic context, the
non-stigmatization and non-discrimination of people based on genetic
information, and other sensitive topics, the use of DNA is something
guaranteed to all civil societies, in line with recommendations made by
international organizations and laws, such as the International
Declaration on Human Genetic Data, Universal Declaration on the
Human Genome and Human Rights, and the Universal Declaration on
Bioethics and Human Rights. However, a question already discussed
[6] with respect to genetic data, is who would have access to
information through DNA analysis? Would this information be
available in a database? To answer these questions, proper regulations
are urgently needed.
Another debatable concern the necessity of storing already
investigated/prosecuted phenotypic information into a database.
Preliminarily, one could argue that there is no necessity in creating a
database of physical characteristics of crime suspects. Furthermore, it
may begin a dangerous debate of enabling research avenues aimed to
associate specific phenotypes with criminal acts. Unfortunately, these
researches are already in development, and we recently reported a
meta-analysis of data demonstrating the lack of association among
facial traits and aggressive behaviors in a large and composite database
[98]. Due to the risk of stigmatization of a particular phenotypic
profile (through the public release of a “molecular portrait” of the
suspect, in analogy to what is known as a “sketch”), police searches
should always be made considering the good sense and decide between
publicly releasing the picture and stealthy tracking. Even when it
comes to EVCs, this weighting is necessary because “four individuals
with red hair in a small town can be more stigmatized than 1000 left-
handed individuals in a medium-sized city” [6]. Finally, the police
intelligence team requires a case-by-case basis.
Final considerations
Theoretically, molecular prediction techniques based on DNA,
RNA, or proteins can be applied to most phenotypes, whether normal
or pathological, or even to detect the many pathogens to which we are
exposed throughout our lives. Although not all of the available
technologies are used in laboratory routines yet, it is expected that
many will be consolidated and implemented in the near future. This is
because the power of current diagnostic technologies has expanded
our knowledge of human (and other species) genetics in an
unprecedented way.
Notably, a very promising avenue of research is the study of DNA
methylation patterns. Despite relatively recent knowledge of
epigenetics, there are already several possible applications. For
example, in forensics, the study of cytosine methylation patterns has
been discussed in literature as an opportunity to differentiate identical
twins based on DNA [99-101]. To our knowledge, there are still very
few protocols to accomplish such tests with a reasonable degree of
certainty. Another method that has been proposed to make such a
differentiation is based on small differences in the DNA sequence
[102,103], particularly using SNPs and other genetic markers (not
based on an epigenetic analysis). Other possible perspectives related to
the epigenetic field include the diagnoses of cancers and other diseases
through the dynamics of DNA methylation [104,105], among other
technologies.
Finally, a broad range of techniques is currently available or in quick
development to be used in many fields of science. Therefore, it is
essential to realize that most issues are not regarding the technology
itself but the use made of it. Discussions such as these should be
encouraged at conferences, meetings, and multidisciplinary seminars,
in order to define proper usage for researchers and specialized
communities, and to clarify the benefits of such technologies for civil
society as a whole.
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